Vuong Trieu Oncotelic Therapeutics, Inc. (OTLC) insider trading activity

OTLC Quotes by TradingView

Vuong Trieu is CHAIRMAN AND CEO of Oncotelic Therapeutics, Inc.. Currently has a direct ownership of 93.3 Million shares of OTLC, which is worth approximately $4.66 Million. The most recent transaction as insider was on Jul 10, 2025, when has been sold 104,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.3M
0.11% 3M change
1.36% 12M change
Total Value Held $4.66 Million

Vuong Trieu Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 10 2025
BUY
Open market or private purchase
-
104,000 Added 0.11%
93,293,560 Common Stock
Jul 09 2025
BUY
Open market or private purchase
-
1 Added 0.0%
93,293,561 Common Stock
Jul 08 2025
BUY
Open market or private purchase
-
94,736 Added 0.1%
93,388,297 Common Stock
Jan 31 2025
BUY
Open market or private purchase
$1,913 $0.03 p/Share
63,775 Added 0.07%
93,189,560 Common Stock
Jan 30 2025
BUY
Open market or private purchase
$3,000 $0.03 p/Share
100,003 Added 0.11%
93,125,785 Common Stock
Jan 29 2025
BUY
Open market or private purchase
$5,491 $0.03 p/Share
183,066 Added 0.2%
93,025,782 Common Stock
Nov 22 2024
BUY
Open market or private purchase
$8,954 $0.03 p/Share
298,499 Added 0.32%
92,842,716 Common Stock
Aug 23 2024
BUY
Open market or private purchase
$10,000 $0.02 p/Share
500,000 Added 0.54%
92,544,217 Common Stock
Jun 29 2023
BUY
Open market or private purchase
$8,500 $0.02 p/Share
425,000 Added 0.46%
92,044,217 Common Stock
Jun 28 2023
BUY
Open market or private purchase
$2,250 $0.03 p/Share
75,000 Added 0.08%
91,619,217 Common Stock
Jun 16 2023
BUY
Open market or private purchase
$3,000 $0.03 p/Share
100,000 Added 0.11%
91,544,217 Common Stock
Jun 14 2023
BUY
Open market or private purchase
$12,000 $0.03 p/Share
400,000 Added 0.44%
91,444,217 Common Stock
May 26 2023
BUY
Open market or private purchase
$3,806 $0.03 p/Share
126,888 Added 0.14%
91,044,217 Common Stock
May 02 2023
BUY
Open market or private purchase
$4,000 $0.04 p/Share
100,000 Added 0.11%
90,917,329 Common Stock
Dec 06 2022
BUY
Open market or private purchase
$6,000 $0.05 p/Share
120,000 Added 0.13%
90,558,021 Common Stock
Nov 22 2022
BUY
Open market or private purchase
$5,600 $0.08 p/Share
70,000 Added 0.08%
90,438,021 Common Stock
Sep 26 2022
BUY
Open market or private purchase
$1,400 $0.07 p/Share
20,000 Added 0.02%
90,368,021 Common Stock
Aug 25 2022
BUY
Open market or private purchase
$6,400 $0.08 p/Share
80,000 Added 0.09%
90,348,021 Common Stock
Jul 08 2021
BUY
Grant, award, or other acquisition
-
259,302 Added 0.29%
90,527,323 Common Stock
Mar 31 2021
BUY
Conversion of derivative security
-
74,455,719 Added 45.2%
90,268,021 Common Stock
Nov 19 2020
BUY
Open market or private purchase
$9,595 $0.19 p/Share
50,500 Added 0.32%
15,812,308 Common Stock
VT

Vuong Trieu

CHAIRMAN AND CEO
Agoura Hills, CA

Track Institutional and Insider Activities on OTLC

Follow Oncotelic Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLC shares.

Notify only if

Insider Trading

Get notified when an Oncotelic Therapeutics, Inc. insider buys or sells OTLC shares.

Notify only if

News

Receive news related to Oncotelic Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OTLC